PYC Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, PYC Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $4.07. The average 1-year stock price forecast is 111.98% higher than the current stock price, while the lowest is $3.20 (+66.67%) and the highest is $5.00 (+160.42%).

Price Target: $4.07 (+111.98%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$3.20	$4.07	$4.10	$5.00
Change	+66.67%	+111.98%	+113.54%	+160.42%

Analyst Ratings

The average analyst rating for PYC Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	4	5	5	5	5	5
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Madeleine Williams Canaccord Genuity	Canaccord Genuity	Buy Maintains $3.20	Buy	Maintains	$3.20	+66.67%	Oct 23, 2026
Yanni Souroutzidis Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Oct 22, 2026
Thomas Wakim Bell Potter	Bell Potter	Buy Maintains $3.00 → $3.30	Buy	Maintains	$3.00 → $3.30	+71.88%	Oct 7, 2026
Unknown Analyst Ord Minnett No rating	Ord Minnett	Buy Maintains $4.10	Buy	Maintains	$4.10	+113.54%	Sep 4, 2026
David Martin PhD Bloom Burton	Bloom Burton	Buy Maintains $5.00	Buy	Maintains	$5.00	+160.42%	Aug 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 25.99M

-100.00%

from 25.99M

Revenue Next Year

n/a

EPS This Year

-0.08

from -0.06

EPS Next Year

-0.09

from -0.08

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	16.04M	15.81M	22.06M	23.49M	25.99M	-
Revenue Growth	421.83%	-1.48%	39.56%	6.51%	10.64%	-100.00%
Operating Income	-14.29M	-23.43M	-38.86M	-53.63M	-57.41M	-118.65M
Net Income	-13.86M	-22.79M	-37.73M	-50.30M	-43.34M	-84.75M
EPS	-	-	-	-	-0.06	-0.08
Free Cash Flow	-	-	-	-	-45.05M	-69.56M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

Chart

EPS	2027	2028	2029
High	-0.05
Avg	-0.08
Low	-0.11

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	-
Avg	-
Low	-